Early colon cancer symptoms, like bloating and abdominal pain, can mimic symptoms of celiac disease, IBS, and gluten ...

People with IBS should still get regular screenings for colon cancer. Dispelling these misconceptions doesn’t mean that you shouldn’t seek treatment for IBS. The knowledge may help you feel ...

About Immuron Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and ...

IBS-D is a subtype of IBS characterized by diarrhea. The triggers can vary among different people, but knowing finding out your potential triggers can help improve your daily life. Lifestyle ...

Dr Ray O’Connor takes a look at some of the most recent clinical studies on irritable bowel syndrome (IBS) ...

Probiotics, which refer to living microorganisms, are another possible treatment for IBS. They are similar to the microorganisms typically present in the digestive tract and may help treat IBS ...

Patients with irritable bowel syndrome are more likely to benefit from a diet that eliminates any food triggering an IgG ...

In addition, developing nations such as China and India present lucrative opportunities for the market's leading participants in treating irritable bowel syndrome. This is due to a large ...

Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 ...

Immuron will launch ProIBS® for the treatment of symptoms related to IBS in the retail pharmacy sales channel. Immuron has been a leader in digestive health in Australia for many years.